Last reviewed · How we verify
Desloratadine placebo tablet — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Desloratadine placebo tablet (Desloratadine placebo tablet) — Organon and Co. This is a placebo tablet containing no active pharmaceutical ingredient and therefore has no mechanistic effect.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Desloratadine placebo tablet TARGET | Desloratadine placebo tablet | Organon and Co | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Desloratadine placebo tablet CI watch — RSS
- Desloratadine placebo tablet CI watch — Atom
- Desloratadine placebo tablet CI watch — JSON
- Desloratadine placebo tablet alone — RSS
Cite this brief
Drug Landscape (2026). Desloratadine placebo tablet — Competitive Intelligence Brief. https://druglandscape.com/ci/desloratadine-placebo-tablet. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab